119 related articles for article (PubMed ID: 15368110)
1. A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.
Cartmell MT; O'Reilly DA; Porter C; Kingsnorth AN
J Hepatobiliary Pancreat Surg; 2004; 11(4):255-9. PubMed ID: 15368110
[TBL] [Abstract][Full Text] [Related]
2. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
4. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
[TBL] [Abstract][Full Text] [Related]
5. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
Lehtimäki L; Petäys T; Haahtela T
Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: a prospective, double-blind, randomized, placebo-controlled study.
Fujiwara H; Konno R; Netsu S; Odagiri K; Taneichi A; Takamizawa S; Ohwada M; Suzuki M
Eur J Obstet Gynecol Reprod Biol; 2010 Feb; 148(2):195-8. PubMed ID: 19944517
[TBL] [Abstract][Full Text] [Related]
7. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis.
Yanase DJ; David-Bajar K
J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482
[TBL] [Abstract][Full Text] [Related]
8. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis.
Bouchelouche K; Nordling J; Hald T; Bouchelouche P
J Urol; 2001 Nov; 166(5):1734-7. PubMed ID: 11586212
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, placebo-controlled, randomized trial of montelukast for acute bronchiolitis.
Amirav I; Luder AS; Kruger N; Borovitch Y; Babai I; Miron D; Zuker M; Tal G; Mandelberg A
Pediatrics; 2008 Dec; 122(6):e1249-55. PubMed ID: 18984650
[TBL] [Abstract][Full Text] [Related]
10. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial.
Veien NK; Busch-Sørensen M; Stausbøl-Grøn B
J Am Acad Dermatol; 2005 Jul; 53(1):147-9. PubMed ID: 15965438
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of montelukast in stable patients with moderate to severe COPD.
Celik P; Sakar A; Havlucu Y; Yuksel H; Turkdogan P; Yorgancioglu A
Respir Med; 2005 Apr; 99(4):444-50. PubMed ID: 15763450
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, placebo-controlled, double-blind study of montelukast's effect on persistent middle ear effusion.
Schoem SR; Willard A; Combs JT
Ear Nose Throat J; 2010 Sep; 89(9):434-7. PubMed ID: 20859868
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
Sanada S; Tanaka T; Kameyoshi Y; Hide M
Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
[TBL] [Abstract][Full Text] [Related]
14. Montelukast for treatment of refractory pruritus in patients on hemodialysis.
Nasrollahi AR; Miladipour A; Ghanei E; Yavari P; Haghverdi F
Iran J Kidney Dis; 2007 Oct; 1(2):73-7. PubMed ID: 19363280
[TBL] [Abstract][Full Text] [Related]
15. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
16. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
18. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
19. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
[TBL] [Abstract][Full Text] [Related]
20. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
